Syllable

United States - Sunnyvale, California

• 25/04/2022
• Series C
• $40,000,000

Syllable brings empathy, transparency, and intelligence to every patient touchpoint outside the hospital.

In 2021, Syllable interacted with 39.7M Americans in text and voice about primary care, specialty referrals, vaccinations, and general practice information.

Syllable was also recognized as a most promising startup in healthcare for 2022 by CB Insights, picked as a leader in the private market from a pool of 7,000 companies – chosen based on R&D activity, proprietary Mosaic scores, market potential, business relationships, investor profile, competitive landscape, team strength, and technology novelty.

Related People

Kobus JoosteFounder

United States - San Francisco Bay Area

CEO of Syllable Syllable delivers artificial intelligence, knowledge management and access solutions for healthcare, with an emphasis on natural language processing.

Kobus is a technology leader and former director of software engineering at Google where he was part of the launch leadership for Google Assistant, worked on Google Search verticals such as knowledge, nutrition, entertainment, transactions and services.

Kobus was the founding engineering lead for Google Life Sciences and Verily, where he built the first FDA certified medical devices for Alphabet. Kobus was also the technical lead for contactless hardware and embedded firmware for Google Wallet and Android Pay at launch.

Prior to Google, Kobus was a technical leader at VMware, IBM Research and various startups in information technology and big data.

LinkedIn https://www.linkedin.com/in/kobusjooste/